Anqiang Wang

4.2k total citations · 2 hit papers
58 papers, 2.5k citations indexed

About

Anqiang Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anqiang Wang has authored 58 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Anqiang Wang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Gastric Cancer Management and Outcomes (11 papers) and RNA modifications and cancer (10 papers). Anqiang Wang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Gastric Cancer Management and Outcomes (11 papers) and RNA modifications and cancer (10 papers). Anqiang Wang collaborates with scholars based in China, United States and Ethiopia. Anqiang Wang's co-authors include Haitao Zhao, Xiaobo Yang, Jianzhen Lin, Zhaode Bu, Jiafu Ji, Xinting Sang, Junyu Long, Xueshuai Wan, Xiaojiang Wu and Yi Zhao and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Communications.

In The Last Decade

Anqiang Wang

56 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pan-cancer single-cell landscape of tumor-infiltrating T cells

2021 699 citations Liangtao Zheng, Shishang Qin et al. Science profile →
Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer

2023 164 citations Chenglong Sun, Anqiang Wang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anqiang Wang China	21	1.2k	884	835	609	520	58	2.5k
Xiaobo Yang China	30	1.0k 0.9×	999 1.1×	1.0k 1.2×	321 0.5×	727 1.4×	100	2.6k
Xiaosong Chen China	30	924 0.8×	1.3k 1.5×	1.5k 1.8×	380 0.6×	381 0.7×	163	3.2k
Shunchang Jiao China	30	1.1k 1.0×	655 0.7×	1.9k 2.2×	618 1.0×	977 1.9×	144	3.4k
Thomas Bachleitner‐Hofmann Austria	30	1.3k 1.1×	1.1k 1.3×	978 1.2×	438 0.7×	300 0.6×	86	2.7k
Bin Cheng China	25	1.1k 0.9×	674 0.8×	729 0.9×	194 0.3×	398 0.8×	103	2.3k
Giuseppe Perrone Italy	27	866 0.7×	563 0.6×	1.2k 1.4×	304 0.5×	536 1.0×	122	2.6k
Andreas Pircher Austria	27	1.7k 1.4×	931 1.1×	1.5k 1.8×	871 1.4×	855 1.6×	103	3.4k
Chunmei Bai China	28	996 0.8×	546 0.6×	1.3k 1.6×	299 0.5×	627 1.2×	173	2.7k
Jianwei Xu China	31	1.2k 1.0×	900 1.0×	951 1.1×	197 0.3×	304 0.6×	93	2.5k
Wang Li China	27	769 0.7×	470 0.5×	543 0.7×	274 0.4×	497 1.0×	108	2.0k

Countries citing papers authored by Anqiang Wang

Since Specialization

Citations

This map shows the geographic impact of Anqiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqiang Wang more than expected).

Fields of papers citing papers by Anqiang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqiang Wang. The network helps show where Anqiang Wang may publish in the future.

Co-authorship network of co-authors of Anqiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Anqiang Wang. A scholar is included among the top collaborators of Anqiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqiang Wang. Anqiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Si, Wen, Sijin Cheng, Haiyin He, et al.. (2025). SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic target. Cellular and Molecular Immunology. 22(11). 1363–1378.

Wang, Anqiang, Ke Ji, Xin Ji, et al.. (2023). Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases. The Journal of Pathology Clinical Research. 10(1). e343–e343. 4 indexed citations

Sun, Chenglong, Anqiang Wang, Yanhe Zhou, et al.. (2023). Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nature Communications. 14(1). 2692–2692. 164 indexed citations breakdown →

Yang, Xuesong, Anqiang Wang, Jialin Li, et al.. (2023). Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS). BMC Cancer. 23(1). 53–53. 5 indexed citations

Zhu, Jiawei, et al.. (2023). Deep-Learning-Based Recovery of Frequency-Hopping Sequences for Anti-Jamming Applications. Electronics. 12(3). 496–496. 7 indexed citations

Ji, Ke, Yue Zhang, Ji Zhang, et al.. (2023). Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach. Cellular Oncology. 47(2). 677–693. 4 indexed citations

Long, Junyu, Peipei Chen, Xiaobo Yang, et al.. (2022). Co-expression of receptor tyrosine kinases and CD8 T-lymphocyte genes is associated with distinct prognoses, immune cell infiltration patterns and immunogenicity in cancers. Translational research. 256. 14–29. 5 indexed citations

Zheng, Liangtao, Shishang Qin, Wen Si, et al.. (2021). Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 374(6574). abe6474–abe6474. 699 indexed citations breakdown →

Liu, Ziyang, Anqiang Wang, Yingying Pu, et al.. (2021). Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach. Oncogene. 40(38). 5705–5717. 30 indexed citations

10.

Chen, Jiahui, Kai Zhou, Anqiang Wang, et al.. (2021). Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer. Annals of Surgical Oncology. 28(8). 4413–4422. 11 indexed citations

11.

Zhang, Yinan, Yiqiang Liu, Anqiang Wang, et al.. (2021). Construction and Validation of a Risk-Scoring Model that Preoperatively Predicts Lymph Node Metastasis in Early Gastric Cancer Patients. Annals of Surgical Oncology. 28(11). 6665–6672. 15 indexed citations

12.

Zhou, Kai, Anqiang Wang, Sheng Ao, et al.. (2020). The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer. 20(1). 671–671. 19 indexed citations

13.

Wang, Anqiang, Zhongwu Li, Meng Wang, et al.. (2020). Molecular characteristics of synchronous multiple gastric cancer. Theranostics. 10(12). 5489–5500. 10 indexed citations

14.

Fu, Tao, Ke Ji, Jin Li, et al.. (2020). ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer. Gastric Cancer. 24(1). 45–59. 49 indexed citations

15.

Wang, Anqiang, Zhongwu Li, Qian Wang, et al.. (2019). Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer. Chinese Journal of Cancer Research. 31(6). 945–954. 8 indexed citations

16.

Long, Junyu, Anqiang Wang, Yi Bai, et al.. (2019). Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 42. 363–374. 252 indexed citations

17.

Wang, Anqiang, Jianzhen Lin, Liangcai Wu, et al.. (2017). Association between proton pump inhibitors and hepatic encephalopathy. Medicine. 96(17). e6723–e6723. 23 indexed citations

18.

Long, Junyu, Jianzhen Lin, Anqiang Wang, et al.. (2017). PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. Journal of Hematology & Oncology. 10(1). 146–146. 84 indexed citations

19.

Wang, Anqiang, Shanshan Wang, Chengpei Zhu, et al.. (2016). Coffee and cancer risk: A meta-analysis of prospective observational studies. Scientific Reports. 6(1). 33711–33711. 67 indexed citations

20.

Wan, Xueshuai, Xiaobo Yang, Anqiang Wang, et al.. (2014). Clinicopathological Features of Gallbladder Papillary Adenocarcinoma. Medicine. 93(27). e131–e131. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact